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Introduction
There is still controversy as to whether temporary (loop) trans-
verse colostomy or temporary (loop) ileostomy is superior as a
temporary faecal diversion for high-risk colorectal or colocolic
anastomosis or other left-sided colonic diseases. Many obser-
vational studies as well as several small randomized controlled
trials (RCTs) so far published to address this question have
produced contradictory conclusions.1–11 We conducted this
overview of all published RCTs and performed a meta-analysis
comparing the complications of these two temporary faecal
diversion methods, to provide a more definitive answer to the
above question. Clinically important heterogeneity between
the RCTs was also examined, as well as the possible sources of
this heterogeneity.
Temporary Ileostomy Versus Temporary Colostomy:
A Meta-analysis of Complications
Patients and methods
We conducted a systematic review of the published literature
retrieved from the following databases: MEDLINE, the
Cochrane database of systematic reviews, the Cochrane con-
trolled trials register, evidence-based medicine reviews and the
American College of Physicians journal club. All the papers
identified in the search were further scrutinized for missed
RCTs by checking their reference lists. There were no language
restrictions and all published materials from the earliest en-
tries in each of the databases were included in the search. Only
RCTs comparing temporary ileostomy with temporary colos-
tomy for faecal diversion in all types of colonic disease were
selected. All relevant RCTs were included regardless of quality
since very few have been published on this subject. Two re-
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searchers conducted the data search independently using
the key words “ileostomy AND colostomy”, and “loop ileos-
tomy AND loop colostomy”. Both researchers abstracted an
identical set of five published RCTs.1–5 The recorded charac-
teristics of patients and of each trial included: total number of
patients in each arm, central tendency for age, proportion of
the sexes, indication for temporary enterostomy, proportion
of cancer cases, length of time to stoma closure, and length of
follow-up time after stoma closure. Outcomes of interest were
the total number of patients with stoma-related complications,
and all listed complications of temporary enterostomy both
before and after stoma closure: complications related to the
presence of a stoma and surgery-related complications. Meta-
analysis was attempted for the total number of patients
experiencing complications, as well as for each complication
individually.
Outcomes of each trial were summarized as proportions
and percentages of complications for both temporary colos-
tomy and temporary ileostomy. Studies for which no particu-
lar outcome was available or that could not be explicitly
expressed as risk ratios were excluded from the analysis for
that particular outcome. Tests for statistical heterogeneity (or
homogeneity tests) were based on the Mantel-Haenszel esti-
mates.12 Both Mantel-Haenszel fixed effects analysis and
DerSimonian and Laird random effects analysis were used to
pool risk ratios of all the studies and calculate 95% confidence
intervals (CI) for all outcomes of interest.12 When statistical or
clinical heterogeneity was detected or suspected, possible
sources of this heterogeneity were investigated by comparing
the methodology and patient characteristics across all trials.13
There was no assessment of publication bias because there
were too few RCTs.14 User-written meta-analysis programmes
in STATA (StataCorp, College Station, TX, USA) were used
for all statistical analyses.15 Statistically significant p values
were set at 0.05 or lower.
Results
Characteristics of each trial are given in Table 1. We will refer
to each trial according to its number given in this table. Overall
number and proportion of patients with the outcomes of
interest are shown in Table 2. Individual complications are
given in Tables 3 and 4 for the period prior to stoma closure
and in Table 5 for the period after stoma closure. With the
exception of the occurrence of post-closure enterocutaneous
fistula (Table 5), all the complications listed in these tables
were reported in at least three of the trials under review.
All trials were small, each with a sample size of less than 100
(Table 1). Patients in all trials were relatively old with similar
central tendencies for age (> 60 years). Trial 3 was a multicen-
Table 1. Characteristics of each trial
Age, yr (range)
Male gender, Colorectal cancer, Days to stoma closure,
Indication for Follow-upTrial n (%) n (%) median (range)
IS CS IS CS IS CS IS CS
enterostomy duration
1. Queen Mary Mean: 65.2 Mean: 67.8 26/42 23/38 42/42 38/38 183 180 Low anterior Not reported
    (2002)1 (61.9)  (60.5)  (100.0) (100.0) resection for
    N = 80 cancer
2. North Hampshire Median: 63 Median: 68 27/34 22/36 33/34 35/36 62 73 Low anterior Median
    (2001)2 (40–80) (32–90) (79.4) (61.1) (97.1) (97.2) (17–120) (28–141) resection for 36 months
    N = 70 cancer after closure
(range, 6–48)
3. Utrecht Mean: 63.2 Mean: 64.7 14/37 13/39 14/37 19/39         Usually 63–84 days All at-risk 12 months
     (1998)3  (26–86) (29–83)  (37.8) (33.3) (37.8)  (48.7) colorectal after closure
     N = 76 surgery
4. Royal Free Mean: 65 Mean: 65 23/32 13/29 27/32 24/29 15 19 All at-risk Not reported
     (1987)4  (46–86)  (44–79)  (71.9)  (44.8)  (84.4)  (82.8)  (10–64)  (9–138) colorectal
     N = 61 anastomosis
5. Leeds Median: 71 Median: 66.5 11/23 12/24 20/23 18/24 77 87.5 Elective at-risk Up to 2.5
     (1986)5  (36–87)  (28–84)  (47.8) (50.0)  (87.0)  (75.0)  (28–148) (49–224) colorectal years after
     N = 47 surgery closure
IS = ileostomy group; CS = colostomy group.
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Table 2. Total number of patients with complications
Pre-closure Post-closure Post-closure
Stoma non-stoma surgical non-surgical Perioperative
complicationsa complicationsa complicationsa complicationsa deaths
Trial  (%) (%) (%)  (%) (%)
IS CS IS CS IS CS IS CS IS CS
1b 6/39 11/38 13/39 8/38 4/35 3/38 0/35 2/38 3/42 0/38
(15.4) (28.9)  (33.3) (21.1) (11.4) (7.9) (5.3) (7.1)
2b 1/33 10/34
– –
1/32 2/31 3/32 1/31 1/34 2/36
(3.0) (29.4) (3.1) (6.5) (9.4) (3.2) (2.9) (5.6)
3b 4/32 0/38c 5/32 1/38 7/29 3/32 1/29 0/32 5/37 1/39
(12.5)c  (15.6)  (2.6)  (24.1) (9.4)  (3.4)  (13.5)  (2.6)
4b 3/31 2/28 8/31 8/28 1/31 1/28
– –
1/32 1/29
(9.7)d  (7.1)d  (25.8)  (28.6) (3.2) (3.6)  (3.1)  (3.4)
5b 3/17 11/19
– –
6/20 2/20
– –
3/23 4/24
(17.6)e  (57.9)e  (30.0)f  (10.0)f  (13.0) (16.7)
M-H  test for heterogeneity:g p 0.065h 0.216 0.488 0.331 0.388
M-H fixed effects summary:g 1.90h 0.67 0.61 0.77 0.62
pooled risk ratio (95% CI) (1.12–3.22)h (0.40–1.44) (0.31–1.20) (0.21–2.84) (0.27–1.43)
Random effects summary: 1.80h 0.69 0.58 0.68 0.74
pooled risk ratio, (95% CI) (0.66–4.88)h (0.33–1.44) (0.28–1.20) (0.13–3.52) (0.29–1.91)
a See definition of terms in the text.
b Study numbers and numbers of patients in each arm of each trial are shown in Table 1. Note that the denominator in the same trial
varies; this depends on patients lost to follow-up or to postoperative death. Some cells are not filled because of lack of information.
c Patients with early stoma complications only.3
d The only occurring stoma complications explicitly counted, with the exception of appliance leakage, were peristomal skin irritation and
parastomal fistula.
e Patients experiencing ≥ 3 stoma-related complications.5
f Three patients in the ileostomy and 1 patient in the colostomy group had early closure of their stoma.5
g M-H test and summary: Mantel-Haenszel test for heterogeneity and summary statistics.
h In Trial 3, M-H test p = 0.252, the fixed effect risk ratio is 2.7 (95% CI, 1.48–4.95) and the random effects risk ratio is 2.5
(95% CI, 1.13–5.52).
IS = ileostomy; CS = colostomy; M-H = Mantel-Haenszel.
tre trial that included younger patients, with a relatively low
proportion of men. There appeared to be an important imbal-
ance between the sexes in Trials 2 and 4, though for Trial 2 this
might have been due to chance occurrence. In all but one trial
(Trial 3), all or an overwhelming majority of patients had
colorectal cancer. The time to closure of the stoma was highly
variable, ranging from a relatively rapid closure after 2 or 3
weeks (Trial 4) to 6 months after stoma formation (Trial 1).
Most trials were in elective surgical patients, except for Trials
3 and 4. In Trial 3, about half the patients in either arm
underwent emergency surgery, while in Trial 4, all patients
underwent temporary enterostomy to protect a high-risk
colorectal anastomosis. Thus, Trial 3 had a more divergent
set of patients. Finally, follow-up time after stoma closure
appeared to vary considerably between the trials.
We defined “stoma complications” as any complication so
defined by the authors of the trial (Table 2). In particular, the
following were considered to be stoma complications: stoma
prolapse, retraction, parastomal hernia, parastomal fistula,
skin irritation due to leakage of intestinal contents and high
stoma output with/without dietary modifications (Table 3).
We explicitly excluded appliance leakage as a stoma complica-
tion since this was not a problem in recent trials.1,2 All other
complications that the authors tabulated in their studies,
whether medical or surgical, were considered non-stoma
complications. Among surgery-related non-stoma complica-
tions were hemorrhage, wound or infectious complications
and intestinal obstruction (Table 4). Post-closure surgical
complications were defined as complications arising after the
closure of the temporary enterostomy that may need surgical
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Table 3. Stoma-related pre-closure complications
Prolapse, Parastomal Parastomal High output/ Skin irritation,
fistula, hernia, dietary change,
Trial n (%) n (%) n (%) n (%) n (%)
IS CS IS CS IS CS IS CS IS CS
1 0/39 3/38
– –
1/39 0/38 1/39 0/38 4/39 7/38
 (7.9) (2.6)  (2.6)  (10.3) (18.4)
2 0/33 2/34 0/33 1/34 0/33 2/34 1/33 0/34
– –(5.9) (2.9) (5.9) (3.0)
3 1/32 16/38 1/32 2/38 2/32 0/38 23/32 4/38 11/32 9/38
(3.1) (42.1)  (3.1) (5.3) (6.3) (71.9)  (10.5)   (34.4)*  (23.7)*
4 0/31 0/28 1/31 1/28
– – – –
2/31 1/28
(3.2) (3.6) (6.5) (3.6)
5 1/17 4/19
– – – – – –
7/17 9/19
(5.9) (21.1) (41.2) (47.4)
M-H test for heterogeneity: p 0.819 0.902 0.264 0.804 0.504
M-H fixed effects summary: 7.77 1.71 0.73 0.17 0.99
pooled risk ratio (95% CI) (2.41–25.03) (0.37–7.91) (0.19–2.86) (0.07–0.40) (0.62–1.58)
Random effects summary: 6.79 1.68 0.67 0.17 0.98
pooled risk ratio (95% CI) (2.02–22.16) (0.36–7.92) (0.09–5.11) (0.07–0.40) (0.62–1.57)
*Patients requiring treatment only. IS = ileostomy; CS = colostomy; M-H = Mantel-Haenszel.
Table 4. Other pre-closure complications and events
Trial Colonic Wound/ Intestinal
anastomosis infectious obstruction,
Appliance Non-closure,
 leakage,  complications, leakage, n (%)
n (%) n (%) n (%) n (%)
IS CS IS CS IS CS IS CS IS CS
1 2/39 2/38
– –
3/39 0/38
– –
4/39 0/38
(5.1)  (5.3)  (7.7)  (10.3)
2 2/33 1/34
– – – – – –
2/33 2/34
(6.1) (2.9)  (6.1)  (5.9)
3
– –
0/32 1/38
– –
12/32 18/38 2/31 2/34
(2.6)  (37.5)  (47.4)  (6.5)  (5.9)
4 2/31 6/28 3/31 4/28 2/31 3/28 21/31 17/28
– –(6.5)  (21.4)  (9.7) (14.3)  (6.5) (10.7)  (67.7)  (60.7)
5 5/19 6/20 3/20 8/18 2/23 2/23 3/17 6/19 0/20 0/20
(26.3)  (30.0)  (15.0)  (44.4)  (8.7)  (8.7)  (17.6) (31.6)
M-H test for heterogeneity: p 0.517 0.754 0.354 0.374 0.401
M-H fixed effects summary: 1.37 2.25 0.77 1.11 0.51
pooled risk ratio (95% CI)  (0.68–2.79)  (0.96–5.28)  (0.27–2.22)  (0.81–1.52)  (0.17–1.58)
Random effects summary: 1.32 2.25 0.92 1.04 0.65
pooled risk ratio (95% CI)  (0.64–2.75)  (0.95–5.34)  (0.28–3.0)  (0.76–1.41)  (0.19–2.18)
IS = ileostomy; CS = colostomy; M-H = Mantel-Haenszel.
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treatment or arising directly from the surgical procedure.
Among such complications were surgical site infection, intes-
tinal obstruction and enterocutaneous fistula (Table 5). Post-
closure non-surgical complications were mostly medical
complications. These included pneumonia, deep vein
thrombosis, pulmonary embolism, respiratory insufficiency,
cardiac arrhythmia, myocardial infarction and urinary
retention.
Although all trials reported some form of stoma com-
plication, not all were reported in the same way. Trials 1, 2
and 4 reported the total number of patients with some form
of stoma complication arising throughout the period prior to
stoma closure, while in Trial 3, this number was reported for
early stoma complications only, and in Trial 5, this was re-
ported for patients with three or more stoma complications.
Under the assumption that comparing these numbers repre-
sented a valid comparison of overall stoma complications, we
pooled the risk ratios of stoma complications for temporary
colostomy over those of temporary ileostomy for all five trials.
The heterogeneity test was of borderline significance (p =
0.065). The pooled fixed effects Mantel-Haenszel estimate of
the overall risk ratio showed a 90% increase in stoma compli-
cations for temporary colostomy over that for ileostomy,
a statistically significant result. The random effects analy-
sis showed a smaller, and non-significant, increase of 80%,
with a markedly wider 95% CI. Trial 3 appeared to be an im-
portant outlier here (Figure 1).
A pooling of post-closure surgical complication risk ratios
revealed no evidence of statistical heterogeneity (p = 0.488)
(Figure 2). The fixed effects and random effects pooled risk
ratios were very similar, with approximately 40% reduction in
complications for colostomy patients, but this was not statis-
Table 5. Post-closure surgical complications
Surgical site infection, Enterocutaneous fistula, Intestinal obstruction and ileus,
n (%) n (%) n (%)
IS CS IS CS IS CS
1 1/35 2/38 1/35 0/38 3/35 1/38
(2.9)  (5.3)  (2.9)  (8.6)  (2.6)
2 1/32 2/31
– –
0/32 1/31
(3.1)  (6.5) (3.2)
3 2/29 1/32 2/29 1/32 2/29 1/32
(6.9)  (3.1)  (6.9)  (3.1)  (6.9)  (3.1)
4 – – – – – –
5 0/20 6/20
– –
2/202 0/20
(30.0)  (10.0)
M-H test for heterogeneity: p 0.331 0.847 0.610
M-H fixed effects summary: 2.47 0.39 0.48
pooled risk ratio (95% CI)  (0.86–7.09)  (0.06–2.56)  (0.15–1.54)
Random effects summary: 1.91 0.40 0.47
pooled risk ratio (95% CI)  (0.52–7.06)  (0.06–2.60) (0.13–1.71)
IS = ileostomy; CS = colostomy; M-H = Mantel-Haenszel.
Figure 1. Forest plot of all trials reporting risk of stoma complications.
Trial 3 is different to other trials. The pooled risk ratio (“overall”)
was calculated using the Mantel-Haenszel fixed effects method.
95% CI = 95% confidence interval.
Trial
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tically significant. A similar tendency was seen for pre-closure
non-stoma complications, post-closure non-surgical compli-
cations and operative deaths, none of which were statistically
significant.
Stoma prolapse was significantly more common in the
colostomy group (no significant heterogeneity between stud-
ies), with a pooled increased risk of almost eight times that
of the ileostomy group (Table 3). High stomal output was sig-
nificantly more common in the ileostomy group (6 times
more common), with the same trend for all trials. However, Trial
3 overwhelmingly dominated this outcome. Only one trial
provided information on stoma retraction (Trial 3: more com-
mon for ileostomies; risk ratio, 0.21; 95% CI, 0.02–1.79). Para-
stomal fistula tended to occur more commonly in the colos-
tomy group, though without statistical significance. There
appeared to be a lower risk of parastomal hernia in the colos-
tomy group, but this was not statistically significant. No trend
was evident for skin irritation caused by the presence of a
stoma.
There was a slightly higher but non-significant risk of
colonic anastomosis (defined as coloanal or colocolic anas-
tomosis) leakage in the colostomy group (almost 40% in-
crease, without significant between-study heterogeneity)
(Table 4). Wound and infectious complications were twice as
common in the colostomy group, a marginally significant
result on both fixed effects and random effects analyses (with
no evidence for heterogeneity). No significant difference was
shown in the risk of gut obstruction, in the occurrence of
appliance leakage, and the rates of non-closure of stoma be-
tween the two groups.
There seemed to be a tendency for more surgical site
infections in the colostomy group, with slight evidence of
heterogeneity (p = 0.331) with considerable difference be-
tween the fixed effects and random effects estimates, but
these studies were dominated by Trial 5 (Table 5). Only two
trials contributed to the calculation of the pooled risk ra-
tio of enterocutaneous fistula following stoma closure,
and there were few such outcomes in each trial. The differ-
ence was thus not statistically significant. There was a com-
mon tendency for a higher risk of gut obstruction or ileus in
the ileostomy group (twice as common), although this was
also not statistically significant.
Discussion
In this study, we compared the complications of temporary
ileostomy with those of temporary colostomy, when used for
protecting high-risk colonic anastomosis or for certain colorec-
tal conditions, in the context of a systematic review and meta-
analysis. When all trials were included in the analysis, several
specific complications were significantly more common for
one type of stoma than the other, but the overall number of
complications did not clearly differ between the two.
There was an increased risk of stoma complications in the
colostomy group for three trials (Trials 1, 2 and 5) and a de-
creased risk in Trials 3 and 4 (Table 2, columns 2 and 3). The
main outlier was Trial 3 (Figure 1). There appeared to be
important heterogeneity between the trials, and the most
important source can be found in Trial 3. We interpreted
borderline significant heterogeneity as important, since het-
erogeneity tests are known to lack statistical power.12 Patients
in that trial included emergency cases as well as conditions
that might be associated with difficult stoma construction
(i.e. intra-abdominal infection and ileus), which may partly
explain the peculiar difference in stoma complications be-
tween the two types of stoma, as well as the relatively high
frequency of these complications (e.g. more stoma prolapse
and retraction, and more cases with skin irritation or appli-
ance leakage). Therefore, it might not be valid to include Trial
3 in a pooled estimate on the basis of difference in reporting
(thus compromising the similarity of patients being pooled)
and the fact that half the sample comprised non-cancer cases.
By excluding Trial 3 from the analysis of overall stoma
complications, we found that between-trial heterogeneity was
no longer so significant, and the pooled risk ratio of the four
Figure 2. Forest plot of all trials reporting risk of post-closure
surgical complications. Trial 2 lies further away from other studies,
but its influence is low. Thus, there is not much evidence of between-
trial heterogeneity. The pooled risk ratio was calculated using the
Mantel-Haenszel fixed effects method. 95% CI = 95% confidence
interval.
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remaining trials increased to 2.7 (95% CI, 1.48–4.95) for the
fixed effects analysis and 2.5 (95% CI, 1.13–5.52) for the ran-
dom effects analysis, both of which are statistically significant.
We may therefore conclude that overall stoma complications
were more frequent for colostomies, when performed elective-
ly, and for colorectal cancer. On the other hand, for patients
undergoing emergency or non-cancer colonic surgery, there
may be a tendency for more stoma complications in the ileos-
tomy group (Trial 3).
Looking at the stoma complications in more detail (Tables
3 and 4), we found that ileostomy was clearly superior to
colostomy in terms of stoma prolapse, even if Trial 3 was
excluded, while no clear advantage could be seen in terms of
peristomal fistula, parastomal hernia, skin irritation or appli-
ance leakage for either type of stoma. High-output stoma was
an important problem for ileostomies, however, but this was
not significant if Trial 3 was excluded. We may conclude that
stoma prolapse was the only stoma complication clearly shown
to be more frequent in the colostomy group, for elective
colorectal cancer patients. On the other hand, for patients
undergoing emergency or non-cancer colonic surgery, there
may be significantly higher risk of ileostomies becoming
high-output stomas (Trial 3).
In terms of non-stoma complications, wound and infec-
tious complications were considerably more frequent in the
colostomy group (more than twice as common, Table 4). Trial
3 reported results in conformity with other trials. Pre-closure
gut obstruction was more common in the ileostomy group,
a result similar to other studies but not statistically signifi-
cant.1,6 Leakages in colonic anastomoses and risk of non-
closure of the stoma were not significantly different between
the two groups. We conclude that wound and infectious
complications were the only non-stoma complications
shown to differ substantially between the two stomas, with
higher risk for colostomies.
Post-closure surgical complications reported as total
number of patients experiencing these complications were
available for all trials (Table 2). There was no statistical differ-
ence between the two groups, but there was a trend towards
fewer complications in the colostomy group. Essentially simi-
lar conclusions were reached after excluding Trial 3. Specific
post-closure surgical complications were not clearly reported
for Trial 4 (Table 5), and since the occurrence of these compli-
cations was relatively rare, statistical significance was also not
achieved for any one of these complications (Table 5). In
particular, occurrence of intestinal obstruction or ileus was
not clearly different between the two groups, although there
was a tendency for more frequent occurrence in the ileostomy
group. Surgical site infection had a tendency to occur more
often in the colostomy group, as in the pre-closure period,
and this might be due to the nature of microbial flora in the
stoma.2,5
It may be noted that there was apparently no logical asso-
ciation between the frequency of complications recorded and
length of follow-up (i.e. cumulative incidence), either during
the period prior to stoma closure or the period thereafter. For
example, Trial 4 with short pre-closure follow-up reported a
higher incidence of non-stoma complications than Trial 1
with much longer pre-closure follow-up; we would have ex-
pected the reverse to be true.2 This could reflect important
differences in case selection and the definition or detection of
complications between trials (see below).
Similarly, no systematic differences in the frequency of any
complications were seen between earlier trials (Trials 4 and
5) and trials performed 10 or more years later (Trials 1, 2 and
3), not even for appliance leakage (which should be less of a
problem now).2 Again, differences in case selection and defi-
nitions of various complications could be the major reason.
As in many systematic reviews and meta-analyses, this
study encountered several methodological problems.16 These
limitations must be considered if the results of this study are
to be appropriately interpreted. First of all, the number of
trials included in this review was rather small. This was com-
pounded by the fact that all the studies also contained small
numbers of patients and some complications did not occur
frequently. Thus, in most instances, the number of pooled
patients was still inadequate for a powerful analysis.
Secondly, the selection of patients was different for each
trial, with the possible exception of Trials 1 and 2, in which
both sets of patients were restricted to elective cases undergo-
ing total mesorectal excision and low anterior resection. In one
case (Trial 3), the selected group of patients differed marked-
ly from that in other trials. This was the main evidence for
clinical heterogeneity between trials. However, this heteroge-
neity may, in fact, be a strength of a meta-analysis if there was
no statistical heterogeneity between the outcomes: this is
because the results may be pooled and, thus, a single result can
be obtained that will be applicable to a wide variety of patients
(i.e. the results will be more generalizable, although this point
is controversial).13 Unfortunately, clinical heterogeneity often
implies statistical heterogeneity,13 as was the case in this study.
Thirdly, information was lacking on the conduct of the
trials (except for a brief description of randomization in Trial
4) and the definitions of the relevant outcomes. This meant
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that randomization might have been inadequate in some trials
(e.g. there was a marked imbalance of male/female patients
between the two arms in Trial 4), the assessment of outcomes
might have been biased (cannot ensure impartial assessment),
and some of the complications recorded might have had
different meanings in different trials (there might be disagree-
ment in the definitions of outcomes). Treatment was different
between trials (surgical techniques were different, as well as
expertise). The differing lengths of follow-up implied differing
cumulative incidences, as mentioned above. Finally, a consid-
erable amount of information was missing on some of the
complications (empty cells in the tables); we cannot determine
how this would influence our results (besides loss of statistical
power).
All these problems limit the possibility and validity of
combining trial outcomes, although, since the comparisons
were made within trials, if the contrasts were similar enough
(e.g. no statistical heterogeneity), an argument may be made
for assuming that a single outcome can represent all trials.
Individual patient data meta-analysis might provide more
information than a meta-analysis of summary results,13 in
particular when comparing the total number of patients with
all complications both before and after stoma closure, or other
comparisons not possible in this analysis. This overview there-
fore strongly points towards a need for a much larger, well-
conducted RCT (with standardized definition of outcomes) to
help definitively settle the question of stoma superiority, since
current evidence is weak either way. There is, however, some
evidence favouring ileostomy in terms of stoma complications
(especially stoma prolapse) and wound or infectious compli-
cations in colorectal cancer patients undergoing elective re-
sections. A recent large retrospective study comparing stoma
complications reached a similar conclusion.7 Other studies to
be conducted in the future should also include other outcome
measures, such as quality of life (as for Trial 3 in a later
publication),17,18 technical difficulty and cost-effectiveness,
since operative complications are not the only outcomes of
interest. For example, only two trials (Trials 2 and 5) attempted
to directly measure technical difficulty in stoma construction
or closure, but they used different measures. Both trials, as
well as anecdotal reports in others (Trials 1 and 3), seemed to
consistently show that closure of a loop colostomy was an
easier procedure. Taking these other outcomes into account
may possibly change the surgeon’s or the patient’s prefer-
ence.6 Finally, we may need to ask ourselves whether or how
another large trial will benefit patient care. Instead of regard-
ing these stomas as competing options, it may be more appro-
priate to regard them as complementary, with their own
usefulness in specific situations.2,5–7 If trials are to be con-
ducted in the future, subgroups of patients, such as emer-
gency colorectal patients, may need to be investigated in de-
tail and explicitly included in the design.
Conclusions
We performed a meta-analysis of all RCTs that compared
complications of temporary ileostomy and those of temporary
colostomy for patients with all types of colorectal disease. Five
trials were reviewed. Stoma complications were more frequent
for colostomy performed in colorectal cancer patients under-
going elective surgery, almost threefold higher. Most signifi-
cant of these complications was stoma prolapse. Pre-closure
infectious and wound complications were also more frequent
(twofold higher) in the colostomy group. Since there was only
one trial with a substantial proportion of emergency and non-
cancer patients (Trial 3), we cannot reach any definite conclu-
sions for this subset of patients. Although there was a ten-
dency for more complications after closure of the stoma in the
ileostomy group, this was not statistically significant.
There was important (statistical and clinical) between-trial
heterogeneity, notably due to case selection. In most instances,
only one trial (Trial 3) contributed outlying results, and re-
moval of this trial significantly decreased between-trial
heterogeneity, at the price of limiting generalizability. Other
potentially important problems were questionable quality
of trial design and conduct, non-standardized outcome
definitions, differences in follow-up time, and lack of other
relevant outcomes of interest. Overall, the meta-analysis still
lacked power for some complications of interest because of
the small pooled sample size (total number of patients = 334)
and relative rarity of the outcomes.
A strong case for superiority of one temporary diverting
stoma over another for all colorectal cancer patients cannot
yet be made. A large, well-conducted RCT will be needed in
this regard. More likely, both temporary colostomy and tem-
porary ileostomy will become complementary diversion
methods (e.g. with their own usefulness in different sub-
groups of patients), rather than competitors.
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